Detalhe da pesquisa
1.
Multicenter, Open-Label, Phase II Study of Bendamustine and Rituximab Followed by 90-Yttrium (Y) Ibritumomab Tiuxetan for Untreated Follicular Lymphoma (Fol-BRITe).
Clin Cancer Res
; 25(20): 6073-6079, 2019 10 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-31243122
2.
Phase 1 trial study of 131I-labeled chimeric 81C6 monoclonal antibody for the treatment of patients with non-Hodgkin lymphoma.
Blood
; 104(3): 642-8, 2004 Aug 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-15100153
3.
Low-dose weekly paclitaxel for recurrent or refractory aggressive non-Hodgkin lymphoma.
Cancer
; 100(11): 2408-14, 2004 Jun 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-15160345